NanoViricides, Inc (NNVC) Stock Price

1.23 ▲ +0.01 (+0.82%)
Open: 1.24 Vol: 335.85K Day's range: 1.23 - 1.28 Dec 05, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
NNVC Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.25▼ 1.24▼ 1.24▲ 1.15▲ 1.40▼
MA10 1.24▼ 1.22▲ 1.19▲ 1.19▲ 1.44▼
MA20 1.21▲ 1.16▲ 1.15▲ 1.34▼ 1.47▼
MA50 1.16▲ 1.17▲ 1.19▲ 1.46▼ 1.40▼
MA100 1.21▲ 1.29▼ 1.36▼ 1.49▼ 1.48▼
MA200 1.33▼ 1.54▼ 1.50▼ 1.42▼ 1.53▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.003▲ 0.015▲ 0.021▲ -0.013▼ -0.034▼
RSI 60.034▲ 60.834▲ 59.915▲ 43.171▼ 41.789▼
STOCH 87.073▲ 88.605▲ 91.991▲ 28.429     26.455    
WILL %R -23.810▲ -13.889▲ -13.514▲ -67.347     -86.206▼
CCI 17.410     61.657     81.265     -10.449     -150.805▼
Latest Filters Detected On NNVC
MA $NNVC Price Crossed Above MA(13) Set Alert
CDL $NNVC Shooting Star Candlestick Pattern Detected Set Alert
CDL $NNVC Doji Star Candlestick Pattern Detected Set Alert
CDL $NNVC Doji Candlestick Pattern Detected Set Alert
NanoViricides, Inc News
NanoViricides Has Signed a Master Services Agreement with OnlyOrphansCote Regarding Orphan Drug Strategy of NV-387 for Treatment of MPox, Smallpox, and Measles
Friday, December 05, 2025 04:27 PM
Detailed price information for Nanoviricides Inc (NNVC-A) from The Globe and Mail including charting and trades.
Investornewsbreaks Nanoviricides (NYSE American: NNVC) Signs Master Services Agreement With Only Orphans Cote For NV-387 Orphan Drug Strategy
Sunday, November 30, 2025 06:04 PM
Signs Master Services Agreement With Only Orphans Cote For NV-387 Orphan Drug Strategy. NanoViricides, Inc. (NYSE American: NNVC), a clinical stage global pioneer in broad-spectrum antivirals based on ...
NanoViricides Has Received Approval to Start Phase II Clinical Trial of NV-387 for the Treatment of MPox by the Regulatory Agency ACOREP of the Democratic Republic of Congo
Monday, November 17, 2025 09:40 AM
SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today reported that it has received approval to Start Phase II Clinical Trial of ...
NNVC historical stock data
date open high low close volume
05/12/25 1.24 1.28 1.23 1.23 335,854
04/12/25 1.11 1.25 1.10 1.22 323,073
03/12/25 1.09 1.11 1.07 1.11 250,073
02/12/25 1.14 1.19 1.09 1.09 391,500
01/12/25 1.22 1.25 1.10 1.12 493,100
28/11/25 1.25 1.27 1.205 1.22 92,330
26/11/25 1.17 1.28 1.17 1.26 210,798
25/11/25 1.20 1.25 1.16 1.17 204,400
24/11/25 1.29 1.29 1.21 1.24 215,600
21/11/25 1.28 1.29 1.22 1.27 196,529
Quote Details
52wk Low:0.94
52wk High:2.23
Vol:335.85K
Avg Vol(3m):5.3M
1Y Chng:-17.45%
1M Chng:-19.61%
Add to Watch List
More Information
Index NYSE AMEX Composite
Market Cap. 21.96M